La traduction de cette page est expérimentale et en cours de développement. N'hésitez pas à vos !
Universal Health Services Croissance future
Future contrôle des critères 1/6
Universal Health Services devrait augmenter ses bénéfices et son chiffre d'affaires de 9.2% et de 5.8% par an respectivement. Le BPA devrait croître de de 10.9% par an. Le rendement des capitaux propres devrait être 16.1% dans 3 ans.
Informations clés
9.2%
Taux de croissance des bénéfices
10.9%
Taux de croissance du BPA
Healthcare croissance des bénéfices | 19.3% |
Taux de croissance des recettes | 5.8% |
Rendement futur des capitaux propres | 16.1% |
Couverture par les analystes | Good |
Dernière mise à jour | 22 Aug 2024 |
Mises à jour récentes de la croissance future
Recent updates
Investors Aren't Entirely Convinced By Universal Health Services, Inc.'s (NYSE:UHS) Earnings
Aug 10We Think Universal Health Services (NYSE:UHS) Can Stay On Top Of Its Debt
Jul 26Universal Health Services: An Underpriced Healthy Business
Jul 04Is Now The Time To Look At Buying Universal Health Services, Inc. (NYSE:UHS)?
Jun 25Returns At Universal Health Services (NYSE:UHS) Appear To Be Weighed Down
Jun 10This Is Why Universal Health Services, Inc.'s (NYSE:UHS) CEO Compensation Looks Appropriate
May 09Universal Health Services, Inc. Just Beat Analyst Forecasts, And Analysts Have Been Updating Their Predictions
Apr 26Market Cool On Universal Health Services, Inc.'s (NYSE:UHS) Earnings
Apr 17Universal Health Services, Inc. (NYSE:UHS) Just Reported And Analysts Have Been Lifting Their Price Targets
Mar 01Is Universal Health Services (NYSE:UHS) Using Too Much Debt?
Feb 20Universal Health Services (NYSE:UHS) Will Want To Turn Around Its Return Trends
Feb 05With Universal Health Services, Inc. (NYSE:UHS) It Looks Like You'll Get What You Pay For
Jan 09Is There An Opportunity With Universal Health Services, Inc.'s (NYSE:UHS) 48% Undervaluation?
Dec 13What Does Universal Health Services, Inc.'s (NYSE:UHS) Share Price Indicate?
Nov 02Capital Allocation Trends At Universal Health Services (NYSE:UHS) Aren't Ideal
Oct 15Universal Health Services (NYSE:UHS) Takes On Some Risk With Its Use Of Debt
Sep 28Universal Health Services: Seeking A Cure For Flat Performance
Sep 11Is Universal Health Services, Inc. (NYSE:UHS) Potentially Undervalued?
Jul 23Universal Health Services: Business Is On The Mend
Jul 12Returns On Capital Signal Tricky Times Ahead For Universal Health Services (NYSE:UHS)
Jul 10Here's Why Universal Health Services (NYSE:UHS) Has A Meaningful Debt Burden
Jun 26Calculating The Fair Value Of Universal Health Services, Inc. (NYSE:UHS)
May 28Should You Think About Buying Universal Health Services, Inc. (NYSE:UHS) Now?
Apr 23Universal Health Services (NYSE:UHS) Could Be Struggling To Allocate Capital
Apr 07Here's Why Universal Health Services (NYSE:UHS) Has A Meaningful Debt Burden
Mar 23Universal Health Services Q4 2022 Earnings Preview
Feb 24Is Universal Health Services, Inc. (NYSE:UHS) Trading At A 31% Discount?
Feb 14Universal Health: Retain Buy As Systematic Defensive Overlay
Feb 04Universal Health Services declares $0.20 dividend
Jan 18Universal Health Services (NYSE:UHS) Will Be Hoping To Turn Its Returns On Capital Around
Jan 05Universal Health Services upgraded at Wells Fargo on improving operating environment
Jan 03Is It Too Late To Consider Buying Universal Health Services, Inc. (NYSE:UHS)?
Dec 21Is Universal Health Services (NYSE:UHS) Using Too Much Debt?
Dec 08Universal Health Services: Attractive Even In Light Of Cost Concerns
Nov 14Is There An Opportunity With Universal Health Services, Inc.'s (NYSE:UHS) 50% Undervaluation?
Nov 10Universal Health net income falls 19% but still good enough for a bottom line beat
Oct 25Universal Health Services (NYSE:UHS) Will Want To Turn Around Its Return Trends
Sep 28Should You Investigate Universal Health Services, Inc. (NYSE:UHS) At US$106?
Sep 13Universal Health Services Is A Buy: Here's Why
Sep 05Is Universal Health Services (NYSE:UHS) Using Too Much Debt?
Aug 31Prévisions de croissance des bénéfices et des revenus
Date | Recettes | Les revenus | Flux de trésorerie disponible | Cash from Op | Moy. Nombre d'analystes |
---|---|---|---|---|---|
12/31/2026 | 17,506 | 1,223 | 1,108 | 1,890 | 13 |
12/31/2025 | 16,581 | 1,135 | 871 | 1,740 | 16 |
12/31/2024 | 15,682 | 1,060 | 1,012 | 1,882 | 16 |
6/30/2024 | 15,018 | 934 | 833 | 1,690 | N/A |
3/31/2024 | 14,658 | 816 | 591 | 1,373 | N/A |
12/31/2023 | 14,282 | 717 | 525 | 1,268 | N/A |
9/30/2023 | 14,025 | 676 | 412 | 1,113 | N/A |
6/30/2023 | 13,799 | 692 | 509 | 1,172 | N/A |
3/31/2023 | 13,574 | 684 | 139 | 841 | N/A |
12/31/2022 | 13,399 | 675 | 262 | 996 | N/A |
9/30/2022 | 13,228 | 739 | 261 | 1,021 | N/A |
6/30/2022 | 13,048 | 774 | 482 | 1,242 | N/A |
3/31/2022 | 12,922 | 935 | 469 | 1,257 | N/A |
12/31/2021 | 12,642 | 990 | 48 | 884 | N/A |
9/30/2021 | 12,454 | 1,059 | -124 | 704 | N/A |
6/30/2021 | 12,210 | 1,081 | 170 | 1,028 | N/A |
3/31/2021 | 11,742 | 1,008 | 1,134 | 1,930 | N/A |
12/31/2020 | 11,559 | 941 | 1,626 | 2,360 | N/A |
9/30/2020 | 11,368 | 878 | 1,842 | 2,552 | N/A |
6/30/2020 | 11,278 | 734 | 1,541 | 2,217 | N/A |
3/31/2020 | 11,404 | 721 | 847 | 1,509 | N/A |
12/31/2019 | 11,378 | 813 | 783 | 1,438 | N/A |
9/30/2019 | 11,237 | 726 | 778 | 1,430 | N/A |
6/30/2019 | 11,063 | 801 | 696 | 1,340 | N/A |
3/31/2019 | 10,889 | 789 | 614 | 1,297 | N/A |
12/31/2018 | 10,772 | 779 | 574 | 1,275 | N/A |
9/30/2018 | 10,661 | 840 | 585 | 1,254 | N/A |
6/30/2018 | 10,554 | 810 | 557 | 1,256 | N/A |
3/31/2018 | 10,485 | 770 | N/A | 1,110 | N/A |
12/31/2017 | 10,410 | 752 | N/A | 1,248 | N/A |
9/30/2017 | 10,243 | 707 | N/A | 1,076 | N/A |
6/30/2017 | 10,111 | 717 | N/A | 1,031 | N/A |
3/31/2017 | 9,929 | 717 | N/A | 1,342 | N/A |
12/31/2016 | 9,766 | 702 | N/A | 1,334 | N/A |
9/30/2016 | 9,606 | 702 | N/A | 1,361 | N/A |
6/30/2016 | 9,424 | 700 | N/A | 1,326 | N/A |
3/31/2016 | 9,268 | 697 | N/A | 1,225 | N/A |
12/31/2015 | 9,043 | 680 | N/A | 1,068 | N/A |
9/30/2015 | 8,905 | 679 | N/A | 1,143 | N/A |
6/30/2015 | 8,716 | 612 | N/A | 1,109 | N/A |
3/31/2015 | 8,492 | 581 | N/A | 1,113 | N/A |
12/31/2014 | 8,205 | 545 | N/A | 1,036 | N/A |
9/30/2014 | 7,830 | 497 | N/A | 998 | N/A |
6/30/2014 | 7,607 | 529 | N/A | 952 | N/A |
3/31/2014 | 7,391 | 529 | N/A | 900 | N/A |
12/31/2013 | 7,368 | 510 | N/A | 884 | N/A |
9/30/2013 | 7,248 | 521 | N/A | 840 | N/A |
Prévisions de croissance des analystes
Taux de revenus par rapport au taux d'épargne: La croissance des bénéfices prévue de UHS ( 9.2% par an) est supérieure au taux d'épargne ( 2.5% ).
Bénéfices vs marché: Les bénéfices de UHS ( 9.2% par an) devraient croître plus lentement que le marché US ( 15.1% par an).
Croissance élevée des bénéfices: Les bénéfices de UHS devraient augmenter, mais pas de manière significative.
Chiffre d'affaires vs marché: Le chiffre d'affaires de UHS ( 5.8% par an) devrait croître plus lentement que le marché de US ( 8.8% par an).
Croissance élevée des revenus: Le chiffre d'affaires de UHS ( 5.8% par an) devrait croître plus lentement que 20% par an.
Prévisions de croissance du bénéfice par action
Rendement futur des capitaux propres
ROE futur: Le retour sur capitaux propres de UHS devrait être faible dans 3 ans ( 16.1 %).